Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryohei Ohtani

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 13, 2019
[PCV chemotherapy]Ryohei Ohtani, Takeo Uzuka, Keisuke Ueki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 13, 2019
[1p/19q co-deletion]Ryohei Ohtani, Takeo Uzuka, Keisuke Ueki
Internal Medicine (Tokyo, Japan)|October 17, 2014
Nasu-Hakola disease revealed on X-rayRyohei Ohtani, Kazumoto Shibuya, Jun-ichi Satoh, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 22, 2015
Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosisAkiyuki Uzawa, Masahiro Mori, Tomohiko Uchida, et al.
Journal of Neuroimmunology|March 13, 2017
Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorderHiroki Masuda, Masahiro Mori, Tomohiko Uchida, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 11, 2015
Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteriaAkiyuki Uzawa, Masahiro Mori, Tomohiko Uchida, et al.
Plos One|April 7, 2020
Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosisHiroki Masuda, Masahiro Mori, Akiyuki Uzawa, et al.
Journal of the Neurological Sciences|February 7, 2018
Validation of the Modified Fatigue Impact Scale and the relationships among fatigue, pain and serum interleukin-6 levels in patients with neuromyelitis optica spectrum disorderHiroki Masuda, Masahiro Mori, Akiyuki Uzawa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 12, 2017
Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis opticaAkiyuki Uzawa, Masahiro Mori, Hiroki Masuda, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2016
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruptionTomohiko Uchida, Masahiro Mori, Akiyuki Uzawa, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 13, 2019
[PCV chemotherapy]Ryohei Ohtani, Takeo Uzuka, Keisuke Ueki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 13, 2019
[1p/19q co-deletion]Ryohei Ohtani, Takeo Uzuka, Keisuke Ueki
Internal Medicine (Tokyo, Japan)|October 17, 2014
Nasu-Hakola disease revealed on X-rayRyohei Ohtani, Kazumoto Shibuya, Jun-ichi Satoh, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 22, 2015
Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosisAkiyuki Uzawa, Masahiro Mori, Tomohiko Uchida, et al.
Journal of Neuroimmunology|March 13, 2017
Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorderHiroki Masuda, Masahiro Mori, Tomohiko Uchida, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 11, 2015
Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteriaAkiyuki Uzawa, Masahiro Mori, Tomohiko Uchida, et al.
Plos One|April 7, 2020
Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosisHiroki Masuda, Masahiro Mori, Akiyuki Uzawa, et al.
Journal of the Neurological Sciences|February 7, 2018
Validation of the Modified Fatigue Impact Scale and the relationships among fatigue, pain and serum interleukin-6 levels in patients with neuromyelitis optica spectrum disorderHiroki Masuda, Masahiro Mori, Akiyuki Uzawa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 12, 2017
Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis opticaAkiyuki Uzawa, Masahiro Mori, Hiroki Masuda, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2016
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruptionTomohiko Uchida, Masahiro Mori, Akiyuki Uzawa, et al.
Pageof 4